Equities

United Health Products Inc

UEEC:PKC

United Health Products Inc

Actions
  • Price (USD)0.1274
  • Today's Change-0.012 / -8.87%
  • Shares traded241.52k
  • 1 Year change-45.79%
  • Beta-0.2272
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

United Health Products, Inc. develops, manufactures, and markets a hemostatic gauze for the healthcare and wound care sectors. Its gauze product, HemoStyp, is derived from cotton and designed to absorb exudate/drainage from superficial wounds and help control bleeding. HemoStyp hemostatic gauze is a flexible, silk-like material that is applied by placing the gauze onto the bleeding tissue. The supple material can be easily folded and manipulated as needed to fit the size of the wound or incision. In surface bleeding and surgical situations, the product quickly converts to a translucent gel that allows the physician or surgeon to monitor the coagulation process. In superficial bleeding situations, HemoStyp can be bonded to an adhesive plastic bandage or integrated into a traditional gauze component to address a range of needs, including traumatic bleeding injuries and prolonged bleeding following hemodialysis. Its customer base includes hospitals, surgery centers, clinics and others.

  • Revenue in USD (TTM)0.00
  • Net income in USD-1.84m
  • Incorporated1997
  • Employees6.00
  • Location
    United Health Products Inc526 Commerce Circle, Ste. #120MESQUITE 89027United StatesUSA
  • Phone+1 (475) 755-1005
  • Websitehttps://uhpcorp.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
DarioHealth Corp19.15m-46.52m30.03m223.00--0.4411--1.57-1.51-1.510.58032.270.162.393.3169,373.19-42.46-73.26-47.52-87.5930.9729.54-265.33-293.541.96--0.2961---26.4122.450.5091--52.42--
Outset Medical Inc116.43m-159.18m30.95m480.00--0.4511--0.2658-3.14-3.142.291.320.35881.583.28242,552.10-49.06-41.40-57.18-47.2928.235.71-136.72-159.055.38-18.390.7417--13.00130.43-6.04--14.27--
IRIDEX Corp49.70m-10.86m32.03m111.00--7.52--0.6444-0.6679-0.66793.060.25811.462.667.84447,747.80-31.84-19.54-54.55-27.4640.4442.67-21.85-15.450.8599--0.00---8.964.02-26.81---24.35--
Icecure Medical Ltd3.34m-13.69m32.19m71.00--3.03--9.65-0.2934-0.29340.07140.21430.17530.843615.0646,985.91-71.93-54.89-92.10-68.6640.3249.87-410.22-313.192.54--0.00--4.6723.5013.70--48.10--
SANUWAVE Health Inc24.90m-3.43m33.08m31.00------1.33-0.0095-0.00950.0218-0.03351.243.908.34803,064.50-17.07-136.54----71.5769.13-13.79-189.600.09990.1199----21.8461.61-150.72------
Vicarious Surgical Inc0.00-61.02m34.56m131.00--0.4795-----10.77-10.770.0012.220.00----0.00-61.68---66.62--------------0.00-------1,478.15------
United Health Products Inc0.00-1.84m34.73m6.00---------0.0075-0.00750.00-0.00810.000.00--0.00-662.95-6,446.86------53.19---132,561.200.0126-15.12-----100.00---55.45------
Accelerate Diagnostics Inc12.23m-37.91m34.81m134.00------2.85-2.07-2.070.6853-1.470.33632.145.2891,291.05-104.22-75.24-1,349.93-94.4627.1635.08-309.87-638.551.04--6.38---5.4316.291.40--0.7307--
Vaso Corp80.33m2.26m35.08m300.0012.961.3111.190.43670.01540.01540.45710.15241.1022.599.62267,766.703.107.605.0416.6261.2058.392.815.821.48--0.0028--2.181.84-57.46---22.33--
Movano Inc852.00k-26.83m35.62m30.00--2.12--41.81-0.4527-0.45270.01310.16960.0444--3.3828,400.00-139.74-151.50-176.37-188.58-87.21---3,149.06--5.23--0.0025------3.45--4.24--
BioNano Genomics Inc36.58m-204.10m36.12m344.00--0.37--0.9874-5.15-5.150.74961.140.18261.005.28106,334.30-101.86-56.82-123.67-67.8328.9725.38-557.98-505.761.11-61.510.0455--29.9024.65-75.34--38.51--
Precision Optics Corporation Inc19.41m-1.64m37.15m84.00--3.15--1.91-0.2706-0.27063.241.861.064.304.51231,098.50-8.98-6.71-13.18-10.5533.6533.65-8.43-5.021.05-8.860.1982--34.2339.1284.42--19.39--
Rapid Micro Biosystems Inc24.71m-50.46m37.29m193.00--0.3942--1.51-1.17-1.170.57112.200.17781.335.58128,036.30-36.30---40.86---14.22---204.22--4.62--0.003--31.44--13.71------
Apyx Medical Corp49.03m-28.37m37.76m252.00--2.56--0.7702-0.8188-0.81881.420.42570.76721.823.96194,567.50-44.55-25.24-58.21-29.9761.9066.11-58.08-46.004.45-7.790.693--17.6125.8219.28--7.99--
T2 Biosystems Inc7.16m-48.26m38.46m113.00------5.37-10.70-10.701.09-0.33910.24352.825.4163,398.23-164.01-106.01---253.03-86.96-12.60-673.67-317.930.359-12.442.00---67.75-7.2919.66---20.19--
electroCore, Inc.21.28m-14.23m38.69m68.00--3.37--1.82-2.19-2.193.251.781.161.4154.85312,955.90-77.78-70.73-125.05-88.9683.6175.81-66.84-352.822.12--0.00--86.5774.4215.02---5.88--
Data as of Sep 20 2024. Currency figures normalised to United Health Products Inc's reporting currency: US Dollar USD

Institutional shareholders

0.07%Per cent of shares held by top holders
HolderShares% Held
Slatestone Wealth LLCas of 30 Jun 2024161.91k0.07%
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.